Bronchopleural Fistula after Lobectomy for Lung Cancer: How to Manage This Life-Threatening Complication Using Both Old and Innovative Solutions.

broncho-pleural fistula lobectomy lung cancer management of broncho-pleural fistula

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 08 02 2024
revised: 08 03 2024
accepted: 09 03 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Our goal is to evaluate the correct management of broncho-pleural fistula (BPF) after lobectomy for lung cancer. We retrospectively reviewed our 25-years' experience and reported our strategies and our diagnostic algorithm for the management of post-lobectomy broncho-pleural fistula. Five thousand one hundred and fifty (5150) patients underwent lobectomy for lung cancer in the period between 1998 and 2023. A total of 44 (0.85%) out of 5150 developed post-operative BPF. In 11 cases, BPF was solved by non-invasive treatment. In nine cases, direct surgical repair of the bronchial stump allowed BPF resolution. In 14 cases, a completion intervention was performed. In six cases, we performed open window thoracostomy (OWT) after lobectomy; in two cases, the BPF was closed by percutaneous injection of an n-butyl cyanoacrylate glue mixture. In two cases, no surgical procedure was performed because of the clinical status of the patient at the time of fistula developing. Thirty-day and ninety-day mortality from fistula onset was, respectively, 18.2% (eight patients) and 22.7% (ten patients). Thirty-day and ninety-day mortality after completion pneumonectomy (12 patients) was, respectively, 8.3% (one patient) and 16.6% (two patients). The correct management of BPF depends on various factors: timing of onset, size of the fistula, anatomic localization, and the general condition of the patient. In the case of failure of various initial therapeutic approaches, completion intervention or OWT could be considered.

Sections du résumé

BACKGROUNDS BACKGROUND
Our goal is to evaluate the correct management of broncho-pleural fistula (BPF) after lobectomy for lung cancer.
METHODS METHODS
We retrospectively reviewed our 25-years' experience and reported our strategies and our diagnostic algorithm for the management of post-lobectomy broncho-pleural fistula.
RESULTS RESULTS
Five thousand one hundred and fifty (5150) patients underwent lobectomy for lung cancer in the period between 1998 and 2023. A total of 44 (0.85%) out of 5150 developed post-operative BPF. In 11 cases, BPF was solved by non-invasive treatment. In nine cases, direct surgical repair of the bronchial stump allowed BPF resolution. In 14 cases, a completion intervention was performed. In six cases, we performed open window thoracostomy (OWT) after lobectomy; in two cases, the BPF was closed by percutaneous injection of an n-butyl cyanoacrylate glue mixture. In two cases, no surgical procedure was performed because of the clinical status of the patient at the time of fistula developing. Thirty-day and ninety-day mortality from fistula onset was, respectively, 18.2% (eight patients) and 22.7% (ten patients). Thirty-day and ninety-day mortality after completion pneumonectomy (12 patients) was, respectively, 8.3% (one patient) and 16.6% (two patients).
CONCLUSIONS CONCLUSIONS
The correct management of BPF depends on various factors: timing of onset, size of the fistula, anatomic localization, and the general condition of the patient. In the case of failure of various initial therapeutic approaches, completion intervention or OWT could be considered.

Identifiants

pubmed: 38539481
pii: cancers16061146
doi: 10.3390/cancers16061146
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Antonio Mazzella (A)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Monica Casiraghi (M)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Clarissa Uslenghi (C)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Riccardo Orlandi (R)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giorgio Lo Iacono (G)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Luca Bertolaccini (L)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Gianluca Maria Varano (GM)

Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Franco Orsi (F)

Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Lorenzo Spaggiari (L)

Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Division of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.

Classifications MeSH